Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
Year: 2010
Type: article
Study design: Clinical Trial
Source: Journal of Neuro-Oncology
Authors: Kurt A. Jaeckle, Karla V. Ballman, Caterina Giannini, Paula J. Schomberg, Matthew M. Ames, Joel M. Reid, Renee M. McGovern, Stephanie L. Safgren, Evanthia Galanis, Joon H. Uhm, Paul D. Brown, Julie E. Hammack, Robert Arusell, Daniel A. Nikcevich, Roscoe F. Morton, Donald B. Wender, Jan C. Buckner
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: G1094409381, G1109514914, G1423238671, G1539327064, G1569511373, National Community Oncology Research Project, Illinois Oncology Research Association Community Clinical Oncology Program, Sanford Community Cancer Consortium, G2082142344, G2383270398, MICHIGAN CANCER RESEARCH CONSORTIUM CCOP, Sanford Community Cancer Program of the North Central Plains (NCORP), G358241105, G3737421695, G42877212, Community Clinical Oncology Program, North Central Cancer Treatment Group, Cedar Rapids Oncology Project, Community Clinical Oncology Program, Duluth Community Clinical Oncology Program, Metro-Minnesota Community Clinical Oncology Program, Sanford Community Cancer Consortium, Iowa Oncology Research Association, G937543590
OpenAlex ID: W2162671591